Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

J. Kimmelman · SciRah

Researcher profile · Semantic Scholar

J. Kimmelman

Share profile

J. Kimmelman — researcher profile on SciRah

h-index: 42
Works: 211
Citations: 7,912

Most-cited papers

ISSCR Guidelines for Stem Cell Research and Clinical Translation: The 2021 update
R. Lovell-Badge, Eric Anthony, R. Barker, T. Bubela +43 more
2021Stem Cell Reports369 citations Open access
Semantic Scholar
Against pandemic research exceptionalism
A. London, J. Kimmelman
2020Science291 citations
Semantic Scholar
The Effect of Overdose Education and Naloxone Distribution: An Umbrella Review of Systematic Reviews.
A. Razaghizad, S. Windle, K. Filion, G. Gore +5 more
2021American Journal of Public Health131 citations Open access
Semantic Scholar
Ethics of controlled human infection to address COVID-19
Seema K. Shah, F. Miller, T. Darton, Devan M. Duenas +18 more
2020Science106 citations
Semantic Scholar
Harms From Uninformative Clinical Trials.
D. Zarin, S. Goodman, J. Kimmelman
2019Journal of the American Medical Association (JAMA)97 citations
Semantic Scholar
Preclinical efficacy studies in investigator brochures: Do they enable risk–benefit assessment?
S. Wieschowski, W. Chin, Carole A. Federico, Sören Sievers +2 more
2018PLoS Biology68 citations Open access
Semantic Scholar
The paradox of precision medicine
J. Kimmelman, I. Tannock
2018Nature Reviews Clinical Oncology64 citations
Semantic Scholar
Consider drug efficacy before first-in-human trials
J. Kimmelman, Carole A. Federico
2017Nature60 citations Open access
Semantic Scholar
Risk and surrogate benefit for pediatric Phase I trials in oncology: A systematic review with meta-analysis
Marcin Waligóra, M. Bała, M. Koperny, M. Wasylewski +10 more
2018PLoS Medicine47 citations Open access
Semantic Scholar
Bystander risk, social value, and ethics of human research
Seema K. Shah, J. Kimmelman, A. Lyerly, H. Lynch +4 more
2018Science46 citations
Semantic Scholar
Potential harms from legalization of recreational cannabis use in Canada
S. Windle, Kristina Wade, K. Filion, J. Kimmelman +2 more
2019Canadian journal of public health42 citations Open access
Semantic Scholar
Inefficiencies and Patient Burdens in the Development of the Targeted Cancer Drug Sorafenib: A Systematic Review
J. Mattina, B. Carlisle, Yasmina Hachem, D. Fergusson +1 more
2017PLoS Biology39 citations Open access
Semantic Scholar
Ethical Considerations for Phase I Trials in Oncology.
M. Bittlinger, Selin Bicer, J. Peppercorn, J. Kimmelman
2022Journal of Clinical Oncology38 citations Open access
Semantic Scholar
Ethical development of stem-cell-based interventions
Amanda MacPherson, J. Kimmelman
2019Nature Medicine37 citations
Semantic Scholar
Individualized therapy trials: navigating patient care, research goals and ethics
P. Kane, M. Bittlinger, J. Kimmelman
2021Nature Medicine35 citations
Semantic Scholar
Clinical Trial Portfolios: A Critical Oversight in Human Research Ethics, Drug Regulation, and Policy.
A. London, J. Kimmelman
2019The Hastings center report31 citations
Semantic Scholar
The proportion of randomized controlled trials that inform clinical practice
Nora Hutchinson, Hannah Moyer, D. Zarin, J. Kimmelman
2022medRxiv28 citations Open access
Semantic Scholar
Assessment of Pregabalin Postapproval Trials and the Suggestion of Efficacy for New Indications: A Systematic Review
Carole A. Federico, Taiji Wang, A. Doussau, J. Mogil +2 more
2019JAMA Internal Medicine28 citations
Semantic Scholar
Evaluation of Journal Registration Policies and Prospective Registration of Randomized Clinical Trials of Nonregulated Health Care Interventions.
M. Azar, Kira E. Riehm, N. Saadat, Tatiana A. Sanchez +10 more
2019JAMA Internal Medicine27 citations Open access
Semantic Scholar
Identifying and understanding factors that affect the translation of therapies from the laboratory to patients: a study protocol
M. Lalu, J. Montroy, C. Begley, T. Bubela +9 more
2020F1000Research26 citations Open access
Semantic Scholar
Risks and benefits of unapproved disease-modifying treatments for neurodegenerative disease
Aden C. Feustel, Amanda MacPherson, D. Fergusson, K. Kieburtz +1 more
2019Neurology26 citations Open access
Semantic Scholar
Can cancer researchers accurately judge whether preclinical reports will reproduce?
Daniel M. Benjamin, David R. Mandel, J. Kimmelman
2017PLoS Biology26 citations Open access
Semantic Scholar
Preclinical efficacy in therapeutic area guidelines from the U.S. Food and Drug Administration and the European Medicines Agency: a cross‐sectional study
Holger Langhof, W. Chin, S. Wieschowski, Carole A. Federico +2 more
2018British Journal of Pharmacology24 citations Open access
Semantic Scholar
The stem cell market and policy options: a call for clarity
A. Zarzeczny, H. Atkins, J. Illes, J. Kimmelman +6 more
2018Journal of Law and the Biosciences24 citations Open access
Semantic Scholar
Imatinib and the long tail of targeted drug development
B. Carlisle, Tiger Zheng, J. Kimmelman
2019Nature Reviews Clinical Oncology23 citations
Semantic Scholar
The Efficacy and Safety of Low Molecular Weight Heparin Administration to Improve Survival of Cancer Patients: A Systematic Review and Meta-Analysis
J. Montroy, M. Lalu, R. Auer, Emma J. M. Grigor +4 more
2020Thrombosis and Haemostasis22 citations
Semantic Scholar
Probability of Success and Timelines for the Development of Vaccines for Emerging and Reemerged Viral Infectious Diseases
Amanda MacPherson, Nora Hutchinson, Oliver Schneider, Elisabeth Oliviero +8 more
2020Annals of Internal Medicine22 citations Open access
Semantic Scholar
The bench is closer to the bedside than we think: Uncovering the ethical ties between preclinical researchers in translational neuroscience and patients in clinical trials
M. Yarborough, A. Bredenoord, F. D’Abramo, N. Joyce +5 more
2018PLoS Biology22 citations Open access
Semantic Scholar
A systematic review and meta-analysis of pregabalin preclinical studies.
Carole A. Federico, J. Mogil, T. Ramsay, D. Fergusson +1 more
2020Pain19 citations
Semantic Scholar
Is preclinical research in cancer biology reproducible enough?
P. Kane, J. Kimmelman
2021eLife17 citations Open access
Semantic Scholar
Practical Steps to Identifying the Research Risk of Pragmatic Trials
Scott Y. H. Kim, J. Kimmelman
2022Clinical Trials16 citations Open access
Semantic Scholar
Proportion of Patients in Phase 1 Oncology Trials Receiving Treatments that are Ultimately Approved.
Sean X Zhang, D. Fergusson, J. Kimmelman
2020Journal of the National Cancer Institute16 citations Open access
Semantic Scholar
Assessing the Completeness of Reporting in Preclinical Oncolytic Virus Therapy Studies
D. Fergusson, Neil L. Wesch, Garvin J. Leung, Jenna MacNeil +12 more
2019Molecular Therapy: Oncolytics16 citations Open access
Semantic Scholar
Trials that say “maybe”: the disconnect between exploratory and confirmatory testing after drug approval
B. Carlisle, Carole A. Federico, J. Kimmelman
2018British medical journal16 citations Open access
Semantic Scholar
The Effect of Overdose Education and Naloxone Distribution: An Umbrella Review of Systematic Reviews.
A. Razaghizad, S. Windle, K. Filion, Genevieve C Gore +5 more
2021American Journal of Public Health15 citations
Semantic Scholar
EDITORIAL
J. Cook, D. Fergusson, I. Ford, M. Gönen +3 more
2019Clinical Trials14 citations Open access
Semantic Scholar
Can Oncologists Predict the Efficacy of Treatments in Randomized Trials?
Daniel M. Benjamin, David R. Mandel, T. Barnes, M. Krzyzanowska +3 more
2020The Oncologist13 citations Open access
Semantic Scholar
Clarifying the Ethics and Oversight of Chimeric Research
J. Johnston, I. Hyun, C. Neuhaus, K. Maschke +21 more
2022The Hastings center report12 citations Open access
Semantic Scholar
Principal investigators over-optimistically forecast scientific and operational outcomes for clinical trials
Daniel M. Benjamin, S. Hey, Amanda MacPherson, Yasmina Hachem +6 more
2022PLoS ONE12 citations Open access
Semantic Scholar
Patient Participation in Clinical Trials of Oncology Drugs and Biologics Preceding Approval by the US Food and Drug Administration
Nora Hutchinson, B. Carlisle, A. Doussau, Rafia Bosan +4 more
2021JAMA Network Open12 citations Open access
Semantic Scholar
How informative were early SARS-CoV-2 treatment and prevention trials? a longitudinal cohort analysis of trials registered on ClinicalTrials.gov
Nora Hutchinson, Katarzyna Klaś, B. Carlisle, J. Kimmelman +1 more
2021medRxiv12 citations Open access
Semantic Scholar
Clinical development success rates and social value of pediatric Phase 1 trials in oncology
M. Wasylewski, K. Strzebonska, M. Koperny, Maciej Polak +2 more
2020PLoS ONE12 citations Open access
Semantic Scholar
Regulating impact on bystanders in clinical trials: an unsettled frontier
N. Eyal, J. Kimmelman, Lisa G Holtzman, M. Lipsitch
2019Clinical Trials11 citations Open access
Semantic Scholar
Phase I trials as therapeutic options: (usually) a betrayal of evidence-based medicine
J. Kimmelman
2019Nature Reviews Clinical Oncology11 citations
Semantic Scholar
Participant Protection in Phase 1 Pediatric Cancer Trials
J. Kimmelman, Marcin Waligóra, H. Lynch
2019JAMA pediatrics10 citations Open access
Semantic Scholar
Expert Forecasts of COVID-19 Vaccine Development Timelines
P. Kane, Hannah Moyer, Amanda MacPherson, J. Papenburg +3 more
2020Journal of general internal medicine9 citations Open access
Semantic Scholar
Ethical and Policy Issues for Seamless Phase I Oncology Trials.
Nora Hutchinson, Esther Vinarov, A. Iasonos, J. Kimmelman
2019Journal of Clinical Oncology9 citations
Semantic Scholar
The Challenges of Validating in Precision Medicine: The Case of Excision Repair Cross-Complement Group 1 Diagnostic Testing.
Brianna Barsanti-Innes, S. Hey, J. Kimmelman
2017The Oncologist9 citations Open access
Semantic Scholar
Predicting Clinical Trial Results: A Synthesis of Five Empirical Studies and Their Implications
J. Kimmelman, David R. Mandel, Daniel M. Benjamin
2023Perspectives in biology and medicine8 citations Open access
Semantic Scholar
Why IRBs should protect bystanders in human research.
J. Kimmelman
2020Bioethics8 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

D. Fergusson×11
Invite
D. Fergusson — researcher profile on SciRah
Carole A. Federico×6
Invite
Carole A. Federico — researcher profile on SciRah
Amanda MacPherson×6
Invite
Amanda MacPherson — researcher profile on SciRah
B. Carlisle×5
Invite
B. Carlisle — researcher profile on SciRah

Nora Hutchinson

×5

Invite

Nora Hutchinson — researcher profile on SciRah

Marcin Waligóra×4

Invite

Marcin Waligóra — researcher profile on SciRah

Daniel M. Benjamin×4

Invite

Daniel M. Benjamin — researcher profile on SciRah

David R. Mandel×4

Invite

David R. Mandel — researcher profile on SciRah

Invite

S. Windle — researcher profile on SciRah

Invite

K. Filion — researcher profile on SciRah

M. Eisenberg×3

Invite

M. Eisenberg — researcher profile on SciRah

Invite

H. Lynch — researcher profile on SciRah